Trial intelligence / Profile preview

Sevoflurane vs Propofol +/- Remifentanil in ECT

NCT01759589Phase 4Completed

Sponsor
Inonu University
Start
Jan 2011
Primary completion
May 2011
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of sevoflurane, propofol injection (veterinary), remifentanil in major depressive disorder (MDD), schizophrenia, sponsored by Inonu University. Started Jan 2011; status: completed.

02

Drugs

sevofluranepropofol injection (veterinary)remifentanil
03

Conditions

major depressive disorder (MDD)schizophrenia

Beyond the preview

Go deeper on NCT01759589.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01759589.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call